Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 19-Sep-24
Select bar for recommendation details.
Recommendations | 19-Sep-24 | |
---|---|---|
Buy | 1 | |
Outperform | 2 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 3 analysts offering 12 month price targets for Aprea Therapeutics Inc have a median target of 16.00, with a high estimate of 20.00 and a low estimate of 11.00. The median estimate represents a 447.95% increase from the last price of 2.92.
High | 584.9% | 20.00 |
Med | 447.9% | 16.00 |
Low | 276.7% | 11.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Nov 07, 2024.
Average growth rate | +8.69% |
Average growth rate | +18.97% |
More ▼
Revenue history & estimates in USD
Average growth rate | +650.23% |
Average growth rate | 0.00% |
More ▼